Search Results - "Heal, D"
-
1
Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines
Published in Neuropharmacology (01-03-2023)“…Research on classical psychedelics (psilocybin, LSD and DMT) and entactogen, MDMA, has produced a renaissance in the search for more effective drugs to treat…”
Get full text
Journal Article -
2
Psychedelics: Threshold of a Therapeutic Revolution
Published in Neuropharmacology (15-09-2023)“…This Special Issue of Neuropharmacology on psychedelics provides a timely and comprehensive update on progress following the previous Neuropharmacology Special…”
Get full text
Journal Article -
3
Face masks: protecting the wearer but neglecting the aquatic environment? - A perspective from Bangladesh
Published in Environmental challenges (Amsterdam, Netherlands) (01-08-2021)“…•An estimate of COVID-related single-use plastic usage and waste in Bangladesh is provided.•The potential impact of single-use face masks on plastic pollution…”
Get full text
Journal Article -
4
The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety
Published in Neuropharmacology (01-12-2009)“…Results from in vivo techniques, especially intracerebral microdialysis in freely-moving rats, have provided insights into potential mechanisms responsible for…”
Get full text
Journal Article -
5
COVID-19 impacts on the Bangladesh shrimp industry: A sequential survey-based case study from southwestern Bangladesh
Published in Fisheries science (01-11-2022)“…Shrimp farming is fundamental to the national economy of Bangladesh, particularly through earning foreign currency. The nationwide lockdown and international…”
Get full text
Journal Article -
6
Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders
Published in Pharmacology & therapeutics (Oxford) (01-02-2008)“…The increasing global prevalence of obesity unequivocally demonstrates that neither behavioural (diet and exercise) nor pharmacological approaches to this…”
Get full text
Journal Article -
7
Preclinical assessment of the abuse potential of purified botanical cannabidiol: self-administration, drug discrimination, and physical dependence
Published in The Journal of pharmacology and experimental therapeutics (01-07-2022)“…Cannabidiol (CBD) is a constituent of the cannabis plant with a diverse array of pharmacological activities as well as potential therapeutic uses. An oral…”
Get full text
Journal Article -
8
A review of late-stage CNS drug candidates for the treatment of obesity
Published in International Journal of Obesity (01-01-2013)“…Obesity is an important causative factor in morbidity, disability and premature death. Increasing levels of obesity will impose enormous health, financial and…”
Get full text
Journal Article -
9
Lisdexamfetamine and immediate release d-amfetamine – Differences in pharmacokinetic/pharmacodynamic relationships revealed by striatal microdialysis in freely-moving rats with simultaneous determination of plasma drug concentrations and locomotor activity
Published in Neuropharmacology (01-11-2012)“…Lisdexamfetamine mesylate (Vyvanse®) is a novel prodrug approved for attention deficit hyperactivity disorder (ADHD). It is metabolised to d-amfetamine and…”
Get full text
Journal Article -
10
New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD
Published in Pharmacology, biochemistry and behavior (01-08-2008)“…Attention deficit hyperactivity disorder (ADHD) is a common childhood psychiatric condition that is effectively treated by catecholaminergic drugs with a…”
Get full text
Journal Article -
11
P.1.g.074 Acquired binge-eating behaviour produces alterations in dopaminergic neurochemistry in the brains of rats
Published in European neuropsychopharmacology (01-10-2014)Get full text
Journal Article -
12
-
13
P.1.g.032 Metabolic effects of lisdexamfetamine in a rat model of human obesity with insulin resistance
Published in European neuropsychopharmacology (01-10-2013)Get full text
Journal Article -
14
P.1.g.034 Effect of lisdexamfetamine in a rat model of binge-eating disorder
Published in European neuropsychopharmacology (01-10-2013)Get full text
Journal Article -
15
Increasing disease burden and use of drugs and chemicals in Bangladesh shrimp aquaculture: A potential menace to human health
Published in Marine pollution bulletin (01-11-2021)“…Using structured surveys in 2008 and 2016, change in disease burden and use of chemical treatments in Bangladesh shrimp farm management was examined. Overall,…”
Get full text
Journal Article -
16
Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine
Published in International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity (01-08-1998)“…Sibutramine (BTS 54 524; N-[1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl]-N,N-dimethylamine hydrochloride monohydrate) is a novel 5-HT (serotonin) and…”
Get more information
Journal Article -
17
A comparison of the effects on central 5‐HT function of sibutramine hydrochloride and other weight‐modifying agents
Published in British journal of pharmacology (01-09-1998)“…1 Effects on 5‐HT function of sibutramine and its active metabolites, BTS 54 354 and BTS 54 505, were compared with fluoxetine, (+)‐fenfluramine and…”
Get full text
Journal Article -
18
Thermogenic effects of sibutramine and its metabolites
Published in British journal of pharmacology (01-03-1999)“…The thermogenic activity of the serotonin and noradrenaline reuptake inhibitor sibutramine (BTS 54524; Reductil) was investigated by measuring oxygen…”
Get full text
Journal Article -
19
In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor
Published in The Journal of pharmacology and experimental therapeutics (01-11-1997)“…Because monoamine reuptake inhibitors and releasing agents both increase extracellular neurotransmitter levels, establishing in vivo experimental criteria for…”
Get more information
Journal Article -
20
Pharmacological Differences Between Rat Frontal Cortex and Hippocampus in the Nicotinic Modulation of Noradrenaline Release Implicate Distinct Receptor Subtypes
Published in Nicotine & tobacco research (01-11-2012)“…Noradrenergic mechanisms in frontal cortex and hippocampus are relevant to attentional and stress-related aspects of addiction, respectively. Nicotinic…”
Get full text
Journal Article